Glyn Edwards appointed interim chief executive of the BioIndustry Association
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards
The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …
Lucentis not backed by NICE for new licence
November 24, 2011Sales and Marketing Lucentis, NICE, Novartis, Ozurdex
NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …
Professor Sir Michael Rawlins reappointed as NICE chairman
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins
The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …
Private sector role in NHS commissioning opposed
November 23, 2011Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters
Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …
Future of public health uncertain, says Forum
November 23, 2011Sales and Marketing Future Forum, NHS, NHS reforms
The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …
Red Door launches Grapevine ‘localisation’ service
November 23, 2011Medical Communications Grapevine, Red Door
Red Door Communications has launched Grapevine – a new healthcare ‘localisation’ initiative and appointed Alasdair Williams as its head. Grapevine …
Pfizer hatches mail order plan for Lipitor
November 23, 2011Sales and Marketing Lipitor, Pfizer, US, generics
Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
Big pharma counts cost of R&D decline
November 23, 2011Research and Development Deloitte, GSK, IIR, R&D productivity
Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …
Merck pays $950 million to settle Vioxx charges
November 23, 2011Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing
Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …
Pharmalink elects Anders Wiklund as its new board chairman
November 23, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink
Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …
Pancreatic cancer sees lowest improvement in cancer survival
November 23, 2011Medical Communications, Research and Development Cancer, Macmillan, pancreatic
A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates. The study …
Changes to the EMA’s registration process for SMEs
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …
Doxil shortages exacerbated as Ben Venue shutters plant
November 22, 2011Manufacturing and Production Doxil, J&J, JJ, manufacturing and production
An acute shortage of Johnson & Johnson’s cancer drug Doxil (doxorubicin) in the US could get worse following a decision …
Pharma manufacturing news in brief
November 22, 2011Manufacturing and Production manufacturing and production
Pfizer and Julphar plan facilities in Saudi Arabia, plus updates from Custom Processing Services, Metrics and China’s Tianyin Pharma. Gulf …
Contract research news in brief
November 22, 2011Manufacturing and Production manufacturing and production
UCB forges strategic alliances with Parexel and PRA, Icon wins a contract for a phase III trial of a traditional …
AstraZeneca appoints two new senior leaders in its Americas division
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca
AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …
Thomas Thorp promoted to senior director of corporate affairs at Lilly UK
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly
Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …
Lucentis rival gains US approval
November 22, 2011Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche
A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …
Gilead aims for hep C lead with Pharmasset acquisition
November 22, 2011Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C
Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
